文献速递乳腺外科围术期管理与 ERAS

乳房切除与假体再造术后急性和晚期并发症的发生时间

The Timing of Acute and Late Complications Following Mastectomy and Implant-based Reconstruction.
PubMed 文献 · Ann Surg · 2022-07-15

该回顾性队列纳入6年间1473例患者、2434个再造乳房,分析假体再造术后并发症的时间分布。12个月累积发生率:血肿1.4%、血清肿4.3%、感染3.2%、皮瓣坏死3.9%、包膜挛缩5.7%、假体波纹7.1%、假体丢失3.9%。42.3%并发症发生在术后60天内,血肿94%、皮瓣坏死85%、血清肿75%在此期间;包膜挛缩94%和假体波纹93%发生在60天后。

要点

  • 术后60天内集中发生血肿、皮瓣坏死和血清肿,需重点监测。
  • 感染和假体丢失约半数发生在60天内,另一半在后期。
  • 包膜挛缩和假体波纹绝大多数在60天后出现,需长期随访。

核心结论

  • 乳房切除与假体再造术后并发症呈现明确的时间分布特征。

研究设计与样本

  • 回顾性连续系列,纳入6年间接受乳房切除与假体再造的患者1473例、再造乳房2434个。

主要发现

  • 共识别785例次并发症/不良结局。
  • 12个月累积发生率:血肿1.4%、血清肿4.3%、感染3.2%、皮瓣坏死3.9%、包膜挛缩5.7%、假体波纹7.1%、假体丢失3.9%。
  • 332/785(42.3%)并发症发生在术后60天内;血肿94%、皮瓣坏死85%、血清肿75%在此期间。
  • 感染和假体丢失各约半数发生在60天内。
  • 包膜挛缩94%和假体波纹93%发生在60天后。

临床怎么用

  • 术后60天内重点监测血肿、皮瓣坏死和血清肿。
  • 感染和假体丢失需在60天内及之后持续警惕。
  • 包膜挛缩和假体波纹需长期随访至60天后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVE: Implant-based breast reconstruction is a common plastic surgery procedure with well-documented clinical outcomes. Despite this, the natural history and timing of key complication endpoints are not well described. The goal of this study is to determine when patients are most likely to experience specific adverse events after implant-based reconstruction. METHODS: Retrospective consecutive series of patients who received mastectomy and implant-based reconstruction over a 6-year period were included. Complications and unfavorable outcomes including hematoma, seroma, wound infection, skin flap necrosis, capsular contracture, implant rippling, and implant loss were identified. A time-to-event analysis was performed and Cox regression models identified patient and treatment characteristics associated with each outcome. RESULTS: Of 1473 patients and 2434 total reconstructed breasts, 785 complications/unfavorable outcomes were identified. The 12-month cumulative incidence of hematoma was 1.4%, seroma: 4.3%, infection: 3.2%, skin flap necrosis: 3.9%, capsular contracture: 5.7%, implant rippling: 7.1%, and implant loss: 3.9%. In the analysis, 332/785 (42.3%) complications occurred within 60 days of surgery; 94% of hematomas, 85% of skin necrosis events, and 75% of seromas occurred during this period. Half of all infections and implant losses also occurred within 60 days. Of the remaining complications, 94% of capsular contractures and 93% of implant rippling occurred >60 days from surgery. CONCLUSIONS: Complications following mastectomy and implant-based reconstruction exhibit a discrete temporal distribution. These data represent the first comprehensive study of the timing of adverse events following implant-based reconstruction. These findings are immediately useful to guide postoperative care, follow-up, and clinical trial design.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Jimenez RB, Packowski K, Horick N, et al. The Timing of Acute and Late Complications Following Mastectomy and Implant-based Reconstruction. Ann Surg. 2022. PMID: 35837894. doi:10.1097/SLA.0000000000005574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。